Advertisement

l-Arginine prevents stroke-like episodes but not brain atrophy: a 20-year follow-up of a MELAS patient

  • Yanping Wei
  • Liying Cui
  • Bin Pen
Letter to the Editor
  • 14 Downloads

Dear Editor,

Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) usually presents with stroke-like episodes (SLEs), progressive encephalopathy, lactic acidosis, migraine headaches, exercise intolerance, and multisystem involvement [1]. SLEs represent the clinical signature of MELAS with a relapsing-remitting pattern [1]. The prognosis of MELAS is determined by the frequency and severity of SLEs, the progression of diffuse encephalopathy, and the involvement of multiple systems. The pathogenesis of SLEs has not been fully elucidated, but recent investigations have found that SLEs are metabolic stroke driven by seizure activity, and other non-ischemic cellular mechanisms may be involved [2]. Meanwhile, growing evidence has indicated that nitric oxide (NO) deficiency occurs in MELAS syndrome and can contribute significantly to endothelial cell dysfunction [3]. Arginine supplementation has been reported to decrease the frequency and severity of SLEs [4]....

Notes

Acknowledgements

We thank the patient and her family, as well as the medical staff of the Peking Union Medical College Hospital.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    El-hattab AW, Adesina AM, Jones J, Scaglia F (2015) MELAS syndrome: clinical manifestations , pathogenesis , and treatment options. Mol Genet Metab 116(1–2):4–12.  https://doi.org/10.1016/j.ymgme.2015.06.004 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Iizuka T, Sakai F, Suzuki N, Hata T, Tsukahara S, Fukuda M, Takiyama Y (2002) Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 59(6):816–824.  https://doi.org/10.1212/WNL.59.6.816 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    El-Hattab AW, Emrick LT, Chanprasert S, Craigen WJ, Scaglia F (2014) Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome. Int J Biochem Cell Biol 48(1):85–91.  https://doi.org/10.1016/j.biocel.2013.12.009 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Tanabe Y, Fujimoto S, Matsuishi T (2005) L-arginine improves the symptoms of stroke-like episodes in MELAS. Neurology 64:710–712CrossRefPubMedCentralGoogle Scholar
  5. 5.
    DiMauro S, Hirano M, Schon E A (2000) Mitochondrial encephalomyopathies: therapeutic approaches. [Review] [75 refs]. Neurol Sci 21(5:Suppl) Suppl-8Google Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Neurology, Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople’s Republic of China

Personalised recommendations